Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

Name: Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
Published: 2023
License: Public Domain

Heinrich-Heine University, Duesseldorf · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

myelodysplastic syndromes, secondary acute myeloid leukemia, chronic myelomonocytic leukemia, mds, saml, cmml, allogeneic blood stem cell transplantation, venetoclax, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

Related documents